Cover Story

  • Sanjeevani for AYUSH

    AYUSH could be the answer to India's unmet medical needs but only if it is backed by scientific validation and credible evidence

  • Taking the green path

    Express Pharma analyses efforts to make the formulation development and drug discovery process more sustainable and environment-friendly

  • Leading the pack

    Kanish Malik, President, Operations, Glenmark Pharmaceuticals and SV Veerramani, Founder and Chairman, Fourrts India, explain the philosophy behind their sustainability efforts.

  • Thinking beyond medicines and products

    Vivek P Adhia, Strategy Head – Climate, WRI India, Tanvi Bongale, Sr Project Associate, Climate, WRI India, Shruti Karkhedkar, Air Quality Intern, WRI India, elaborate on how the pharma...

  • We are collaborating with pharma companies worldwide to adopt eco-friendly methods

    Over the years, Ideal Cures’ R&D department has helped pharma companies to adopt eco-friendly methods and increase productivity. Its recent INSTACOAT 4G is a new...

  • The monster in your laboratory

    Sekhar Surabhi, CEO and President at Caliber Technologies, insists on paperless automation and recommends a shift to a completely automated, paperless laboratory

  • Operational excellence with sustainability: Lessons from Lindström

    Lindström, which provides rental workwear solutions for the pharmaceutical sector has adopted various environmentally-friendly ways to achieve significant cost benefits, reveals its recently released Sustainability...

  • Skilling Up

    Skilling has emerged a priority in India’s pharma sector with LSSSDC, industry associations and consultants spearheading initiatives in this direction. Yet, are all the pieces needed to plug the...

  • Strategies for making high pharmaceutical quality affordable: Part II

    Dr Ajaz S Hussain, Former Deputy Director Office of Pharmaceutical Science, US FDA, currently Founder of Insight, Advice & Solutions, US and President, National Institute...

  • Quality excellence through skill development

    SM Mudda, Chairman, Regulatory Affairs Committee, IDMA and Director - Global Strategy (Technical), Micro Labs, emphasises the need to adopt a Quality Management Systems...

  • Building pharma quality: From the top-floor to the shop-floor

    Vikas Bhadoria, Senior Partner and Vivek Arora, Associate Partner, McKinsey & Company, emphasise on the need to build a strong quality culture, which will lead...

  • Skill level directly impacts quality, which has a direct impact on human life

    Ranjit Madan, CEO, Life Science Sector Skills Development Council links skill levels in the pharmaceutical sector, quality and safety of medicines, and India's global market...

  • Regulatory compliance at the shop floor is a key gap that needs to be bridged

    Hemant Deshpande, Managing Partner, Pollux Life Science Solutions, in an interaction with Viveka Roychowdhury, elaborates on the skill gap between academia and industry and how...

  • NSF’s education courses, like the APPQM, change the way people think

    Medicines are only as good as the people making them, points out Martin Lush, Global Vice President, Pharma Biotech and Medical Devices, NSF Health Sciences....

  • Driving Innovation The NDDS Way

    The need for a multidisciplinary approach to deliver greater therapeutic results has opened new avenues for growth in the novel drug delivery systems market. In this issue,...

  • Bliss GVS Pharma: Overcoming social bias

    Bliss GVS Pharma has managed to break through the social bias against suppositories and pessaries in the Sub-Saharan African market. After years of research on...

  • Zim Laboratories: On the growth path

    Zim Laboratories' oral disintegrating strips is the latest offering of this Nagpur based company's NDDS portfolio by Usha Sharma

  • Generating value in generics

    Utkarsh Palnitkar, Partner and Head, Infrastructure, Government and Healthcare, Life Sciences, KPMG in India, gives an insight on the importance to develop NDDS by Indian...

  • IPR Building Block or Stumbling Block?

    With World Intellectual Property Day round the corner, Express Pharma explores the evolving IPR scenario in India and its impact on pharma companies

  • Patent system, only way to promote innovation?

    Yogesh Pai, Assistant Professor of Law and Co-Director of the Centre for Innovation, Intellectual Property and Competition (CIIPC) at National Law University, Delhi counters the...

  • A balancing act

    Ashish Prasad, Partner, Economic Laws Practice Delhi, analyses IPR in India, elaborates on the need to evolve an effective IPR policy to encourage innovation without...

  • Techniques to enhance IP valuations

    Dr Gopakumar G Nair, CEO, Gopakumar Nair Associates, gives an insight on why IP systems must support innovations by creating a conducive environment to attract...

  • On the right track

    Ashwin Sapra, Partner, and Biplab Lenin, Consultant, Cyril Amarchand Mangaldas, give an insight on how adequate research and development, intellectual property protection protocols and enforcement...

  • Hedging against uncertainty in the IPR Regime: Contractual protections

    Anay Shukla, Lead, Pharma Healthcare team, Darren Punnen, Member, Pharma Healthcare team and Vidya Phanse, Intern, Nishith Desai Associates, discuss contractual strategies that companies engaged...

  • The Bt cotton saga

    Rajeev Kumar, Partner, LexOrbis provides a commentary on the facts and questions of law that are raised in the current Bt. cotton patent infringement suit...

  • Rooting out Rubella: Making it Mission Possible

    The government needs to quash fears about safety of the rubella vaccine and establish its efficacy to achieve its goal of eliminating the disease by 2020

  • The Social Way to Success

    India Pharma Inc needs to leverage the potential of social media to up its game in times to come